Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-15T09:49:20.394Z Has data issue: false hasContentIssue false
  • English
  • Français

Structural Alterations in Depression: Cellular Mechanisms Underlying Pathology and Treatment of Mood Disorders

Published online by Cambridge University Press:  07 November 2014

Ronald S. Duman
Get access Rights & Permissions [Opens in a new window]

Abstract

Basic and clinical studies over the past 10 years have lead to a fundamental shift in our understanding of mood disorders. These studies demonstrate that mood disorders and stress are accompanied by structural alterations in the brain; moreover, these structural alterations are reversible with antidepressant treatment. These alterations include changes in the length and number of neuronal processes, the number of neurons and glia, and even the rate of neurogenesis in the adult brain. Work is also being conducted to identify the molecular mechanisms underlying these changes and the adaptations that are critical to the therapeutic actions of antidepressant treatment. Some of the intracellular targets include second messengers, gene transcription factors, and neurotrophic factors that could oppose the actions of stress and depression. Taken together, this exciting new work describes and details structural alterations of limbic brain regions that are extremely dynamic and adaptive. Further understanding of the abnormalities in these systems that lead to mood disorders will provide more efficacious and possibly faster-acting therapeutic interventions.

Type
Feature Article
Information
CNS Spectrums , Volume 7 , Issue 2 , February 2002 , pp. 140 - 147
Copyright
Copyright © Cambridge University Press 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Manji, H, Duman, RS. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics. Psychopharmacol Bull. 2001;35:5–49.Google ScholarPubMed
2.Bremner, JD, Randall, P, Scott, TM, et al.MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am J Psychiatry. 1995;152:973–981.Google ScholarPubMed
3.Sheline, YI, Wang, PW, Gado, MH, Csernansky, JG, Vannier, MW. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A. 1996;93:3908–3913.CrossRefGoogle ScholarPubMed
4.Sheline, YI, Sanghavi, M, Mintun, MA, Gado, MH. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci. 1999;19:5034–5043.CrossRefGoogle Scholar
5.Drevets, WC, Price, JL, Simpson, JR, et al.Subgenual prefrontal cortex abnormalities in mood disorders. Nature. 1997;386:824–827.CrossRefGoogle ScholarPubMed
6.Hirayasu, Y, Shenton, ME, Salisbury, DF, et al.Subgenual cingulate cortex volume in first-episode psychosis. Am J Psychiatry. 1999;156:1091–1093.CrossRefGoogle ScholarPubMed
7.Rajkowska, G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry. 2000;48:766–777.CrossRefGoogle ScholarPubMed
8.Ongur, D, Drevets, WC, Price, JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A. 1998;95:13290–13295.CrossRefGoogle ScholarPubMed
9.Benes, F, Kwok, EW, Vincent, SL, Todtenkopf, MS. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry. 1998;15:88–97.CrossRefGoogle Scholar
10.McEwen, B. Stress and hippocampal plasticity. Curr Opin Neurobiol. 1999;5:205–216.CrossRefGoogle Scholar
11.Conrad, C, Magarinos, AM, LeDoux, JE, McEwen, BS. Repeated restraint stress facilitates fear conditioning independently of causing hippocampal CA3 dendritic atrophy. Behav Neurosci. 1999;113:902–913.CrossRefGoogle ScholarPubMed
12.Duman, R, Malberg, J, Nakagawa, S. Regulation of adult neurogenesis by psychotropic drugs and stress. J Pharmacol Exp Ther. 2001;299:401–407.Google ScholarPubMed
13.Gage, F. Mammalian neural stem cells. Science. 2000;287:1433–1438.CrossRefGoogle ScholarPubMed
14.Gould, E, Beylin, A, Tanapat, P, Reeves, A, Shors, TJ. Learning enhances adult neurogenesis in the hippocampal formation. Nat Neurosci. 1999;2:260–265.CrossRefGoogle ScholarPubMed
15.Cameron, H, McKay, RDG. Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus. J Comp Neurol. 2001;435:406–417.CrossRefGoogle ScholarPubMed
16.Duman, R, Nakagawa, S, Malberg, J. Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology. In press.Google Scholar
17.Czeh, B, Michaelis, T, Watanabe, T, et al.Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci U S A. 2001;98:12796–12801.CrossRefGoogle ScholarPubMed
18.Gould, E, McEwen, BS, Tanapat, P, Galea, LAM, Fuchs, E. Neurogenesis in the dentate gyrus of the adult tree shrew is regulated by psychosocial stress and NMDA receptor activation. J Neurosci. 1997;17:2492–2498.CrossRefGoogle ScholarPubMed
19.Tanapat, P, Hastings, NB, Rydel, TA, Galea, LAM, Gould, E. Exposure to fox odor inhibits cell proliferation in the hippocampus of adult rats via an adrenal hormone-dependent mechanism. J Comp Neurol. 2001;437:496–504.CrossRefGoogle ScholarPubMed
20.Bremner, J, Vythilingam, M, Vermetter, E, Charney, DS. Failure of hippocampal activation in recurrent depression. Abstr Soc Neurosci. In press.Google Scholar
21.Magarinos, A, Deslandes, A, McEwen, BS. Effects of antidepressants and benzodiazepine treatments on the dendritic structure of CA3 pyramidal neurons after chronic stress. Eur J Pharmacol. 1999;371:113–122.CrossRefGoogle ScholarPubMed
22.Watanabe, Y, Gould, E, Daniels, DC, Cameron, H, McEwen, BS. Tianeptine attenuates stress-induced morphological changes in the hippocampus. Eur J Pharmacol. 1992;222:157–162.CrossRefGoogle ScholarPubMed
23.Jacobs, B, van Praag, H, Gage, FH. Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol Psychiatry. 2000;5:262–269.CrossRefGoogle ScholarPubMed
24.Malberg, J, Eisch, AJ, Nestler, EJ, Duman, RS. Chronic antidepressant treatment increases neurogenesis in adult hippocampus. J Neurosci. 2000;20:9104–9110.CrossRefGoogle Scholar
25.Manev, H, Uz, T, Smalheiser, NR, Manev, R. Antidepressants alter cell proliferation in the adult brain in vivo and in neural cultures in vitro. Eur J Pharmacol. 2000;411:67–70.CrossRefGoogle Scholar
26.Chen, G, Rajkowska, G, Du, F, Seraji-Bozorgzad, N, Manji, HK. Enhancement of hippocampal neurogenesis by lithium. J Neurochem. 2000;75:1729–1734.CrossRefGoogle ScholarPubMed
27.Madsen, T, Treschow, A, Bengzon, J, et al.Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry. 2000;47:1043–1049.CrossRefGoogle Scholar
28.Malberg, J, Eisch, AJ, Nestler, EJ, Duman, RS. Effects of antidepressant treatment and learned helplessness training on hippocampal neurogenesis in adult rat. Soc Neurosci Abstr. 2000;26:1044Google Scholar
29.Duman, R, Heninger, GR, Nestler, EJ. A molecular and cellular theory of depression. Arch Gen Psychiatry. 1997;54:597–606.CrossRefGoogle ScholarPubMed
30.Duman, R, Malberg, J, Nakagawa, S, D'Sa, C. Neuronal plasticity and survival in mood disorders. Biol Psychiatry. 2000;48:732–739.CrossRefGoogle ScholarPubMed
31.Manji, H, Potter, WC, Lenox, RH. Signal transduction pathways. Arch Gen Psychiatry. 1995;52:531–543.CrossRefGoogle ScholarPubMed
32.Nibuya, M, Nestler, EJ, Duman, RS. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci. 1996;16:2365–2372.CrossRefGoogle ScholarPubMed
33.Thome, J, Sakai, N, Shin, K, et al.cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci. 2000;20:4030–4036.CrossRefGoogle ScholarPubMed
34.Duman, R, Marek, G. Neuroanatomical and cellular determinants of depression. In: Kaplan, CB, Hammer, R, eds. Brain Signaling and Circuitry in Psychiatry. Washington, DC: American Psychiatric Press; 2001:193–225.Google Scholar
35.Takahashi, M, Terwilliger, R, Lane, S, Mezes, PS, Conti, M, Duman, RS. Chronic antidepressant administration increases the expression of cAMP phosphodiesterase 4A and 4B isoforms. J Neurosci. 1999;19:610–618.CrossRefGoogle ScholarPubMed
36.Chen, A-H, Shirayama, Y, Shin, K-H, Neve, RL, Duman, RS. Expression of the cAMP response element binding protein (CREB) in hippocampus produces antidepressant effect. Biol Psychiatry. 2001;49:753–762.CrossRefGoogle ScholarPubMed
37.Nibuya, M, Morinobu, S, Duman, RS. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci. 1995;15:7539–7547.CrossRefGoogle ScholarPubMed
38.Rosello-Neustadt, A, Beard, RC, Cotman, CW. Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression. Neuropsychopharmacology. 1999;21:679–682.CrossRefGoogle Scholar
39.Smith, MA, Makino, S, Kvetnansky, R, Post, RM. Stress alters the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci. 1995;15:1768–1777.CrossRefGoogle ScholarPubMed
40.Zigova, T, Pencea, V, Wiegand, S, Luskin, M. Intraventricular administration of BDNF increases the number of newly generated neurons in the adult olfactory bulb. Mol Cell Neurosci. 1998;11:234–245.CrossRefGoogle ScholarPubMed
41.Benraiss, A, Chmielnicki, E, Lerner, K, Roh, D, Goldman, SA. Adenoviral brain-derived neurotrophic factor induces both neostriatal and olfactory neuronal recruitment from endogenous progenitor cells in the adult forebrain. J Neurosci. 2001;21:6718–6731.CrossRefGoogle ScholarPubMed
42.Pencea, V, Bingaman, KD, Wiegand, SJ, Luskin, MB. Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum, thalamus, and hypothalamus. J Neurosci. 2001;21:6706–6717.CrossRefGoogle ScholarPubMed
43.Siuciak, JA, Lewis, DR, Wiegand, SJ, Lindsay, R. Antidepressant-like effect of brain derived neurotrophic factor (BDNF). Pharmacol Biochem Behav. 1997;56:131–137.CrossRefGoogle ScholarPubMed
44.Shirayama, Y, Chen, ACH, Duman, RS. Antidepressant-like effects of BDNF and NT-3 in behavioral models of depression. Abstr Soc Neurosci. 2000;26:1042.Google Scholar